BATF represses BIM to sustain tolerant T cells in the periphery

J Exp Med. 2023 Dec 4;220(12):e20230183. doi: 10.1084/jem.20230183. Epub 2023 Oct 20.

Abstract

T cells that encounter self-antigens after exiting the thymus avert autoimmunity through peripheral tolerance. Pathways for this include an unresponsive state known as anergy, clonal deletion, and T regulatory (Treg) cell induction. The transcription factor cues and kinetics that guide distinct peripheral tolerance outcomes remain unclear. Here, we found that anergic T cells are epigenetically primed for regulation by the non-classical AP-1 family member BATF. Tolerized BATF-deficient CD4+ T cells were resistant to anergy induction and instead underwent clonal deletion due to proapoptotic BIM (Bcl2l11) upregulation. During prolonged antigen exposure, BIM derepression resulted in fewer PD-1+ conventional T cells as well as loss of peripherally induced FOXP3+ Treg cells. Simultaneous Batf and Bcl2l11 knockdown meanwhile restored anergic T cell survival and Treg cell maintenance. The data identify the AP-1 nuclear factor BATF as a dominant driver of sustained T cell anergy and illustrate a mechanism for divergent peripheral tolerance fates.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoantigens
  • Bcl-2-Like Protein 11 / genetics
  • Clonal Anergy*
  • T-Lymphocytes, Regulatory
  • Transcription Factor AP-1*

Substances

  • Transcription Factor AP-1
  • Bcl-2-Like Protein 11
  • Autoantigens